Leptomeningeal Disease Not Yet Recruiting Phase 1 Trials for Afatinib (DB08916)

Also known as: Metastases to meninges / Malignant meningitis / Meningeal Carcinomatosis

IndicationStatusPhase
DBCOND0075962 (Leptomeningeal Disease)Not Yet Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03711422Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLCTreatment